NINTEDANIB ESYLATE vs SPRYCEL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. NINTEDANIB ESYLATE and SPRYCEL are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NINTEDANIB ESYLATE	SPRYCEL
Rating	New	72/100
Pharmacy pays	—	~$839.19 /30
Type	RX	RX
Active ingredient	NINTEDANIB ESYLATE	DASATINIB
Manufacturer	Dr Reddys	Bristol Myers Squibb
Dosage forms	Capsule	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Idiopathic Pulmonary Fibrosis	Lymphoid Leukemia, Myeloid Leukemia

nintedanib esylate sprycel

Rating

New

72/100

Pharmacy pays

—

~$839.19 /30

Type

Active ingredient

NINTEDANIB ESYLATE

DASATINIB

Manufacturer

Dr Reddys

Bristol Myers Squibb

Dosage forms

Capsule

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Idiopathic Pulmonary Fibrosis

Lymphoid Leukemia, Myeloid Leukemia

Frequently asked questions

What is the difference between Nintedanib Esylate and Sprycel?

Nintedanib Esylate contains Nintedanib Esylate, while Sprycel contains Dasatinib — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.